APA   Click to copy
Bharti, V., Weiss, V., Shen, C., Chen, S.-C., Blevins, A., Shattuck-Brandt, R., … Vilgelm, A. (2021). Abstract 1054: Patient derived organoids demonstrate synergistic antitumor effect of senogenic and senolytic drug combination of Aurora kinase inhibitor and BCL2/xL inhibitor. Experimental and Molecular Therapeutics.

Chicago/Turabian   Click to copy
Bharti, V., V. Weiss, Chengwu Shen, Sheau-Chiann Chen, Ashlyn Blevins, R. Shattuck-Brandt, A. Richmond, and A. Vilgelm. “Abstract 1054: Patient Derived Organoids Demonstrate Synergistic Antitumor Effect of Senogenic and Senolytic Drug Combination of Aurora Kinase Inhibitor and BCL2/XL Inhibitor.” Experimental and Molecular Therapeutics (2021).

MLA   Click to copy
Bharti, V., et al. “Abstract 1054: Patient Derived Organoids Demonstrate Synergistic Antitumor Effect of Senogenic and Senolytic Drug Combination of Aurora Kinase Inhibitor and BCL2/XL Inhibitor.” Experimental and Molecular Therapeutics, 2021.

@article{v2021a,
  title = {Abstract 1054: Patient derived organoids demonstrate synergistic antitumor effect of senogenic and senolytic drug combination of Aurora kinase inhibitor and BCL2/xL inhibitor},
  year = {2021},
  journal = {Experimental and Molecular Therapeutics},
  author = {Bharti, V. and Weiss, V. and Shen, Chengwu and Chen, Sheau-Chiann and Blevins, Ashlyn and Shattuck-Brandt, R. and Richmond, A. and Vilgelm, A.}
}